IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL)
2 Bekeken
• 07/02/23
0
0
insluiten
administrator
abonnees
In this month’s “Hot Topic,” Dr. Curt Hanson will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53 sequencing in these patients.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties